Prevention

Latest News


Latest Videos


More News

Infection Control Today Infection Intel: Staying Ahead With Company Updates and Product Innovations.

Infection Intel: News From Healthmark, Henry Schein, APIC, and GP PRO

Published: | Updated:

Infection Intel is a new column for Infection Control Today® (ICT®) that will cover the latest news, including updates on product developments, mergers, and more from companies in the infection control and prevention field.

Shannon Simmons, DHSc, MPH, CIC, MLS (ASCP) Photo courtesy of the author)

This personal narrative highlights the career path of an individual who transitioned from a passion for microbiology to becoming an infection preventionist. She overcame obstacles through education, internships, and determination and held a crucial role in health care during the COVID-19 pandemic, showcasing the transformative power of education and dedication.

ICT's Product Locator column

ICT's Product Locator: September/October 2023

Published: | Updated:

Infection Control Today's® Product Locator is a monthly column highlighting some of the latest advanced technology in the infection prevention field.

Photo of doctor's hands holding legs of a newborn in an incubator in a  neonatal intensive care unit.  (Adobe Stock, 464090504 by Iryna)

Infection Prevention in the NICU: A Changing Landscape

Published: | Updated:

In the delicate world of neonatal care, every precaution is taken to protect premature infants in the Neonatal Intensive Care Unit (NICU). It's crucial to acknowledge the strides made in safeguarding these vulnerable infants, whose wellbeing hinges on the meticulous efforts of health care professionals and evolving best practices.

 MIS-C (Adobe Stock 350657530 by Bernard Chantal)

Fibi Attia, MD, MP, CIC, and her colleagues conducted a study on multisystem inflammatory syndrome in children (MIS-C) linked to COVID-19. The study focused on the characteristics, implications, and outcomes of MIS-C cases, particularly cardiac dysfunction. The interview discusses the study's goals and key findings, stressing the importance of detecting MIS-C cases and the need for more research on COVID-19 vaccines.